Taking one week at maintenance every eight to ten weeks may actually accelerate long-term progress
In a phase 1, 6-week randomized controlled trial (RCT) that included scores on the Food Craving Questionnaire-State, the Food Craving Inventory, the Eating Inventory, the Power of Food Scale, and an appetite Visual Analogue Scale as secondary outcomes, tirzepatide was associated with reductions in appetite, hunger, cravings, tendency to overeat, and reactivity to environmental food cues, versus placebo [9]
Now with modern technology we can harness those anti-inflammatory effects to provide long term benefits, whether thats a reduction in psoriasis symptoms, decreased risk of cardiovascular disease, possibly less risk of dying from infection and who knows what else
According to one study, the supplementation of LA (600 mg/d, IV (17 days)
However, some patients experience no symptoms until day 5 or 7, especially if starting at a lower microdose